WOLVERINE ASSET MANAGEMENT LLC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 54 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 8.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$36,000
-34.5%
28,789
+8.7%
0.00%
Q3 2017$55,000
+1.9%
26,474
+41.6%
0.00%
-100.0%
Q2 2017$54,000
-37.9%
18,700
-27.0%
0.00%0.0%
Q1 2017$87,000
-22.3%
25,600
-60.6%
0.00%0.0%
Q4 2016$112,000
-41.7%
64,900
+11.9%
0.00%
-66.7%
Q3 2016$192,00058,0000.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
GLG LLC 1,524,143$1,966,0000.14%
BVF INC/IL 734,976$948,0000.11%
Old West Investment Management, LLC 77,254$99,0000.06%
Telemetry Investments, L.L.C. 64,464$83,0000.03%
Baupost Group 2,226,839$2,873,0000.03%
NEA Management Company, LLC 370,900$478,0000.02%
IFG Advisory, LLC 49,000$63,0000.01%
Rock Springs Capital Management LP 165,300$213,0000.01%
Virtu Financial LLC 50,290$65,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 133,658$172,0000.00%
View complete list of OREXIGEN THERAPEUTICS INC shareholders